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Discussion
Dr Glen Van Arsdell (Toronto, Ontario, Canada). Dr Caldarone,
my partner, was the invited commentator. He was unable to be
here. I am providing what are essentially his comments.
This is an impressive report describing TCE for bicuspid aortic
valves compared with the Ross procedure. The results have been
analyzed with an appropriate degree of caution, recognizing the
variable nature of outcomes with leaflet extension.
The hallmark of a good operation is one that is easily repro-
duced and produces consistent results. In this respect, I think that
at the Hospital for Sick Children we are still in a development
phase with the leaflet extension technique. We have some diffi-
culty verbalizing why some valves simply do not appear to be
repairable. We know them when we see them, but cannot always
say why. And when we do repair a valve, we have difficulty
determining what technical details lead some to develop progres-
sive insufficiency while others do not.
The solution for this dilemma is the development of a finer
vocabulary describing the anatomy of the valve disease and better
description of the components of the procedure performed. With a
better vocabulary we can develop more consistency in our tech-
niques and move the leaflet extension technique from an artistic
operation to a more consistent, reproducible, and durable proce-
dure.
Along the lines of better description of the problems, my
questions are as follows:
The bicuspid aortic valve represents a spectrum of development
from a well-developed but fused commissure to a nearly absent
rudimentary raphe. One would anticipate better results with tricus-
pidization in the presence of a well-developed but fused commis-
sure. Are you able to comment on the degree of development of the
fused commissure and the impact that this had on your intraoper-
ative decision-making, as well as the durability of the subsequent
repair?
Dr McMullan. All the patients in this study had a bicuspid valve
with a well-developed raphe. We believe that a well-developed raphe
is necessary for this type of repair because it implies the presence of
three coronary sinuses; we think that this type of valve should benefit
from returning to a three-cusp type of physiology.
Dr Van Arsdell. So is it fair to infer that if it is really a true
bicuspid valve with almost no hint of autotricuspidization, you
recommend a Ross operation?
Dr McMullan. Yes, we would perform a Ross operation or
perhaps a different type of repair.
Dr Van Arsdell. A large proportion of your patients had
undergone balloon aortic valvuloplasty before their surgical pro-
cedure. Typically this results in tearing of the leaflet rather than the
commissure. The tear tends to extend to the base of the cusp. Does
the morphology of the tear dictate the choice between a Ross and
a leaflet extension technique? Furthermore, do all torn leaflets
require leaflet extension or can they be repaired by other published
techniques?
Dr McMullan. The selection criteria for repair, as outlined in
the talk, indicate that any involvement of the hinge point, the
lowest portion of the valve leaflet, would preclude repair. The idea
Appendix Figure 1. Actuarial freedom from reoperation for aortic
valve repair for bicuspid aortic valve (Royal Children’s Hospital,
1996-1998) with preservation of the bicuspid physiology. N  5. The
only patient of the 5 with a long-term satisfactory result has not had
a cusp extension with pericardium. The other 4 had cusp extension.
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is to avoid a suture line that limits valve mobility. A larger
percentage of patients in the Ross group had balloon dilation.
Therefore, according to our selection criteria, they underwent a
Ross procedure.
Dr Van Arsdell. If I am understanding your answer correctly,
you really would not construct something where the predominant
proportion of the leaflet is derived from pericardial tissue; is that
correct?
Dr McMullan. That is correct. Two patients required extensive
leaflet replacement early in the study. Those patients experienced
early failure.
Dr Van Arsdell. Finally, I think that the problems we face are
that some of the valves we want to repair are mixed lesions and
frequently these involve patients who had previous aortic stenosis
issues. The question is, a priori, before the operation, are you able
to decide, based on echocardiographic criteria and your preoper-
ative evaluation, with some degree of probability (ie, gradients or
characteristics of mobility in the leaflet), which patients on a
probability basis are going to need a Ross operation versus those
that would need a repair?
Dr McMullan. This is an important question. We feel believe
the outcome of both procedures should improve with the appro-
priate selection of patients. According to our selection criteria, a
patient with pure aortic insufficiency or a large annulus would be
more suitable for repair, whereas patients with a negative z-value
for the annulus should receive a Ross–Konno procedure. Because
our decision to perform one procedure over another was based on
several factors, it is difficult to say whether any single factor would
significantly affect the outcome of these procedures. This was not
a randomized study; it is likely that we directed patients who were
at higher risk for a Ross toward valve repair, and vice versa.
Consequently, multivariate analysis of potential risk factors did not
identify any factors that contributed to early failure. This supports
the appropriateness of our selection criteria.
Dr Van Arsdell. I would say, based on reading your manu-
script and listening to your presentation, that you have less residual
stenosis than we do. This implies that we are making a different
intraoperative decision to repair valves that are going to have a net
less orifice. Perhaps we are being more aggressive about the raphe
than you are. I’m not sure that this is the right decision. We need
to begin to grapple with that and figure out which patients are best
served.
Dr Bahaaldin Alsoufi (Toronto, Ontario, Canada). Obviously
when you repair the valve, you try to make it function as close to
normal as possible. In reality, you do not leave the operating room
with a normal valve and often you have some residual defects,
either stenosis or regurgitation. To further correct residual regur-
gitation, you may cause worsening stenosis. Those residual lesions
will progress with time and may contribute to late repair failure.
How do you manage those patients with residual lesions? How
much gradient do you accept, or how much regurgitation on
postrepair transesophageal echocardiogram will you accept before
you decide to reinstitute cardiopulmonary bypass for either revi-
sion of the repair or replacement of the aortic valve?
Dr McMullan. As Dr Van Arsdell alluded, this is a custom
procedure. It has not been standardized and much of the decision-
making is based on the surgeon’s personal experience and his
comfort level with the amount of residual insufficiency after repair.
In general, if we found more than mild insufficiency after
repair, we would either revise the repair or proceed to a Ross. In
fact, the 2 patients who required early revision were found to have
moderate insufficiency afte the initial repair. We elected to revise
the repair at that time. In general, we do not attempt valve repair
unless we are very confident that we will achieve a satisfactory
result so that we avoid a situation in which we must replace a valve
after unsuccessful repair.
Dr John W. Brown (Indianapolis, Ind). I have two questions.
First, did age of the patient factor into which route you took? You
tried to do a repair on the smaller children to try to let the annulus
grow so you could come back and do a Ross; did that play a role?
I did not get that from your presentation.
Dr McMullan. Age did not factor into our decision-making.
Multivariate analysis of several factors, including age, failed to
identify specific risk factors for failure. However, our decision to
perform either procedure was biased by our stated selection crite-
ria. Perhaps something like age would be identified as a risk factor
for one procedure or the other in a randomized study.
Dr Brown. Second, although the Ross registry is not a perfect
judge of how durable the Ross operation is, there are over 6000
patients in it, and the freedom from autograft excision is still 85%
at 25 years. How do you think the repair technique is going to hold
up? Your follow-up is at about 4 or 5 years at this point, and with
6 late failures, and, as you stated, it would seem that this is a
palliative operation and probably is not going to compete with the
Ross once you get out past 5, 6, or 7 years. Your comments.
Dr McMullan. I agree completely. The Ross is a very good
procedure and, in appropriately selected patients, long-term results
are very good. We are suggesting that this repair technique may be
useful as an adjunct to the Ross procedure. By performing valve
repair in patients who may be poorer candidates for the Ross
procedure, we may avoid negative aspects of the Ross, including
intrinsic weakness of the autograft, disruption of the right ventricular
outflow tract, and converting 1-valve disease to 2-valve disease.
Certainly a large percentage of patients undergoing valve repair
will ultimately move on to valve replacement. It is our hope that by
initially performing valve repair, the patient can safely wait for a
more permanent valve replacement later in life.
Dr Brown. What percentage of these patients do you think will
have a good functioning aortic valve 10 to 15 years after the
repair? Are you predicting 50% or 25%?
Dr McMullan. I think we have shown that this technique of
repair is a good palliative procedure but remains a palliation.
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